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The relationship between metabolic disorders and the distribution of fat in 
different body regions is not clearly understood in humans. The aim of this study 
was to develop a suitable method for assessing the regional distribution of fat de-
posits and their metabolic effects in dogs. Twenty-five dogs were subjected to 
computed tomographic (CT) imaging and blood sampling in order to characterise 
their metabolic status. The different fat areas were measured on a cross-sectional 
scan, and the animals’ metabolic status was evaluated by measuring fasting glu-
cose, insulin and leptin levels. The volume of visceral adipose tissue is the main 
determinant of leptin levels. The correlation of visceral fat volume and leptin con-
centration was found to be independent of insulin levels or the degree of insulin 
resistance. There was a positive correlation between the visceral to subcutaneous 
fat volume ratio and serum insulin concentration, and a similar trend was ob-
served in the relationship of fat ratio and insulin resistance. The distribution of 
body fat essentially influences the metabolic parameters in dogs, but the effects of 
adiposity differ between humans and dogs. The findings can facilitate a possible 
extrapolation of results from animal studies to humans with regard to the meta-
bolic consequences of different obesity types.  
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Obesity is a growing problem in companion animals just like in humans. 
The development of insulin resistance, dyslipidaemia and other metabolic prob-
lems appear to be more closely related to the regional distribution of body fat 
than simply to adiposity or body weight. Even though the phenotypes of human 
obesity that represent specific risk factors for metabolic disorders have not been 
reported in dogs, differences in the metabolic effects of increased visceral or 
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subcutaneous adipose tissue volume have been described (Kabir et al., 2005). 
The distribution of adipose tissue in dogs is important for understanding how the 
preferential accumulation of fat into visceral depots instead of subcutaneous ones 
contributes to the pathologic consequences of obesity. 
Over the past few years, dogs have been used as a model of the human 
metabolic syndrome, and to study the link between visceral adiposity and insulin 
resistance (Bergman et al., 2001). Although many human studies have shown 
that different fat depots are quite different metabolically, there is no consensus 
regarding their relative importance (Dusserre et al., 2000). Previous publications 
have suggested that excess intraabdominal fat is the major determinant of insulin 
resistance and of other features of human metabolic syndrome (Fujioka et al., 
1987). A study performed in dogs has demonstrated that the surgical excision of 
omental fat improves insulin sensitivity (Lottati et al., 2009). Other studies re-
ported that the accumulation of abdominal subcutaneous adipose tissue is a better 
predictor of insulin sensitivity than visceral fat (Goodpaster et al., 1997). 
Quantitative estimation of adiposity and fat distribution is essential for ex-
amining the effects of obesity. Most methods used in human medicine are not 
adaptable to dogs because of the variations of their body dimensions. The body 
condition score (BCS) system is the most commonly used method to diagnose 
obesity in the dog and to predict the detrimental health effects, but it is based on 
subjective assessment and does not make it possible to determine the amount of 
visceral and subcutaneous fat separately (Laflamme, 1997). In the human medi-
cal practice, computed tomography (CT) is one of the most advanced methods 
for the accurate assessment of intraabdominal fat accumulation (Hirooka et al., 
2005). Although the CT method using a single image at vertebrae L3–5 is a use-
ful technique for the evaluation of canine obesity and body fat distribution, an 
accurate procedure has been developed for a single breed (the Beagle) only (Ish-
ioka et al., 2005a). 
The adipose tissue is also identified as an endocrine organ that can influ-
ence various physiological processes by releasing metabolically active substrates 
termed adipokines. There are significant differences in the range of adipokine 
production between preadipocytes and mature adipocytes and between cells lo-
calised in different places. Some adipokines (primarily leptin, adiponectin and 
resistin) have been investigated as potential markers of the degree of obesity and 
to assess the risk of development of associated complications (German et al., 
2010). Serum leptin concentration positively correlates with body fat content, 
and therefore it is a useful marker for the quantitative assessment of adiposity in 
dogs, regardless of gender, oestrous cycle, breed and age, although a breed effect 
on leptin level has not yet been completely excluded. Leptin concentrations were 
significantly higher in all breeds of dogs with higher BCSs (Ishioka et al., 2002a; 
Ishioka et al., 2007). Thus, leptin might be a useful factor for the diagnosis of 
obesity and for assessing the progression of related diseases; moreover, it can be 
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used for monitoring fat distribution. Although some researchers have reported 
that the correlation of leptin levels is the highest with visceral fat volume (Ron-
nemaa et al., 1997), most studies have shown that leptin concentration is deter-
mined mainly by the subcutaneous depot because of a higher secretion rate of 
leptin (Cnop et al., 2002). Insulin secretion has been suggested to be an addi-
tional determinant of leptin concentrations (Malmström et al., 1996), and leptin 
levels may increase or decrease the glucose-stimulated insulin secretion, depend-
ing on the condition of individuals and other metabolic circumstances (Ceddia et 
al., 2002). 
The aim of this study was to examine the effect of fat distribution and the 
amount of subcutaneous or visceral fat tissue on leptin concentrations, to assess 
the influence of insulin levels and sensitivity on leptin levels, and to check the 
possibility of a reverse effect. 
 
 
Materials and methods 
Animals and general procedures 
The study complied with the requirements of the animal welfare regula-
tions of Szent István University and was conducted in accordance with the Euro-
pean Animal Welfare Regulations. Twenty-five client-owned dogs of different 
breeds were included in this study. All these dogs were subjected to clinical ex-
aminations and to the estimation of adiposity by BCS on the 5-point scale (Ed-
ney and Smith, 1986). Detailed data, such as breed, age, gender, body condition 
and clinical history, were recorded for each dog. 
Computed tomography 
Computed tomographic scans (Phillips Brillance, 64 slices CT) of 25 dogs 
(16 male, 9 female) examined for diagnostic purposes at the Department of Nu-
clear Medicine of the University of Debrecen (Medical and Health Science Centre) 
were considered in this study. The dogs were subjected to general anaesthesia for 
the procedure. Subcutaneous and visceral fat areas were measured on a cross-
sectional scan (120 Kv, 30 mA, 5 mm slice thickness) at the level of the L2 and L3 
vertebrae (Ishioka et al., 2005a). The pixels with attenuation values in the se-
lected range were depicted as red (Fig 1). The boundary between visceral and 
subcutaneous fat tissue was defined by use of abdominal wall musculature in 
continuity with the deep fascia of the paraspinal muscles. Fat areas were calcu-
lated by dividing the number of pixels counted as fat by the ratio of the total num-
ber of pixels and known area for a 1 cm image, and the area of different fat depos-
its was expressed in square centimetres (cm2). Visceral (IAF) or subcutaneous 
(SCF) fat area percentages were calculated by dividing the fat area by the total 
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area in each slice (IAFxL2, IAFxL3, SCFxL2, SCFxL3) and by dividing the fat 
area with the area of organs (IAForgxL2, IAForgxL3, SCForgxL2, SCForgxL3) 
to ensure the comparability of data from dogs of different body size. 
 
Fig. 1. Computed tomographic (CT) scans. Cross-sectional scans at the level of L2 of four dogs of 
different breeds and conditions (column 1). CT scans indicating the total area of the body in red 
(column 2) and the marked area of visceral (column 3) and subcutaneous fat (column 4) 
Sample collection and hormone assay 
Blood samples were collected from the cephalic vein before the induction 
of anaesthesia. Being aware of the effects of diurnal variations, food intake and 
certain medications on serum leptin concentration (Ishioka et al., 2002b; Ishioka 
et al., 2005b), we used only blood samples collected from dogs that had been 
fasted for at least 10 h and not treated with insulin or glucocorticoids. Blood glu-
cose was measured using an automatic analyzer (Dcont Personal) with a com-
mercial kit, immediately after blood collection. Samples were centrifuged at 
1500 rpm for 12 min at 4 °C, and the serum was separated and chilled until as-
sayed for hormone levels. Hormone determinations were done at the Laboratory 
of the Department and Clinic of Reproduction, Faculty of Veterinary Science, 
Szent István University. Leptin concentrations were determined by the use of a 
direct sandwich ELISA using a goat anti-canine leptin antibody (Canine Leptin 
ELISA, Millipore Corporation, St. Charles, Missouri). The sensitivity for this as-
say is 0.4 ng/ml. Insulin levels were measured by using a solid phase two-site 
ELISA (Mercodia AB, Uppsala, Sweden). It is based on the direct sandwich 
technique in which two monoclonal antibodies are directed against separate anti-
genic determinants on the insulin molecule. The detection limit was 0.01 µg/l. 
Numerical results were obtained using an appropriate ELISA reader (Thermo 
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Labsystems Multiskan RC, Vantaa, Finland) and a computer programme (Ascent 
Thermo Labsystem, Vantaa, Finland). Fasting insulin resistance was estimated 
with Homeostatic Model Assessment (HOMA). HOMA-IR is a simple index of 
insulin resistance based on fasting glucose and insulin levels (Matthews et al., 
1985). This index is calculated as: HOMA-IR = {[fasting insulin (µU/ml)] × 
[fasting glucose (mmol/l)]}/22.5. 
Statistical analysis 
The data are presented as mean ± standard deviation (SD) values. Because 
the variables were not normally distributed, the association between the serum 
leptin levels and the distribution of abdominal fat tissue, serum insulin level or 
insulin sensitivity was determined by Spearman’s rank order correlation. Simple 
and multiple regression analyses were used to find out whether changes in leptin 
levels can explain possible effects of fat distribution, and to evaluate the simulta-
neous contributions of fat distribution and insulin sensitivity to leptin level. Sta-
tistical analyses were made using the R free software (R version 2.9.2, 2009.) A 
P value of < 0.05 was considered as statistically significant. 
 
 
Results 
Condition and fat distribution 
The distribution of dogs according to their BCS was as follows: 17 were 
normal (BCS3), 7 overweight (BCS4) and 1 obese (BCS5). Sixteen were intact 
males and nine intact females. The animals were between 2 and 13 years of age 
(average 8.3). The leptin concentrations were 3.22 ± 3.74 ng/ml in BCS3, 10.4 ± 
7.36 in BCS4 and 16.06 ng/ml in BCS5. Leptin levels were significantly higher 
in dogs with higher BCSs. The insulin level and the HOMA-IR index values 
tended to decline in dogs with higher BCS categories but there was no significant 
difference between them. We successfully determined the distribution of ab-
dominal fat in dogs of different breeds, and the area of different fat depots on the 
CT scans at the level of the L2 and L3 lumbar vertebrae (Fig. 1). The results 
were expressed in proportion of the total area and as a ratio to the area of ab-
dominal organs. 
Effect of fat distribution and insulin concentration on leptin level 
We examined the relationship between the area and the visceral to subcu-
taneous ratio (IAF/SCFxL2, IAF/SCFxL3) of fat depots as a relative index of in-
traabdominal fat accumulation (Fujioka et al., 1987), as well as some metabolic 
parameters. Correlation analysis (Table 1) revealed that there was a significant 
positive correlation between leptin concentration and the area of subcutaneous 
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(0.53–0.61) and visceral fat tissues (0.78–0.83) at the level of L2 and L3. The 
area of subcutaneous fat showed a lower correlation with serum leptin concentra-
tion. Leptin levels did not correlate with the ratio of fat depots, insulin level or 
HOMA-IR. There was a positive correlation between the intraabdominal to the 
subcutaneous fat area ratio and insulin concentration, and a similar trend was ob-
served in the relationship of fat ratio with HOMA-IR. The graphic display (Fig. 2) 
indicates a non-linear relationship between leptin level and the area of visceral 
fat (IAFxL2). We attempted to examine this relationship using log-transformed 
leptin concentration values in the regression models. Linear regression analysis 
showed that leptin concentrations significantly correlated with fat distribution, 
and revealed that leptin levels could be best predicted from visceral fat (IA-
Forg.xL2, R2: 64%; IAFxL2, R2: 62%; SCForg.xL2, R2: 34%; SCFxL2, R2: 
27%), but fat distribution had no significant effect on leptin level. Multiple linear 
regression analysis indicated that fasting serum insulin and HOMA-IR were not 
predictors of leptin level; neither these nor the area of subcutaneous fat tissue in-
fluenced the relationship between leptin levels and the area of visceral fat. 
Table 1 
Spearman’s correlations of leptin and insulin levels and HOMA-IR with each other  
and the parameters of abdominal fat distribution 
 Leptin Insulin HOMA-IR 
N = 25, 
*N = 24 Ρ (rho) P Ρ (rho) P Ρ (rho) P 
IAFxL2 0.78 0.0000 0.22 0.3013 0.21 0.3073 
IAFxL3 0.80 0.0000 0.25 0.2295 0.23 0.2786 
IAForg.xL2 0.79 0.0000 0.15 0.4854 0.13 0.5235 
IAForg.xL3 0.83 0.0000 0.17 0.4107 0.16 0.4515 
SCFxL2 0.53 0.0064 –0.17 0.4225 –0.17 0.4305 
SCFxL3 0.53 0.0062 –0.21 0.3212 –0.19 0.3580 
SCForg.xL2 0.61 0.0011 –0.15 0.4739 –0.15 0.4707 
SCForg.xL3 0.62 0.0009 –0.13 0.5210 –0.14 0.5032 
IAF/ 
SCFxL2 
0.08/ 
0.19* 
0.7035/ 
0.3859* 
0.34/ 
0.41* 
0.1000/ 
0.0476* 
0.34/ 
0.39* 
0.0979/ 
0.0604* 
IAF/ 
SCFxL3 
0.17/ 
0.28* 
0.4222/ 
0.1816* 
0.36/ 
0.44* 
0.0731/ 
0.0304* 
0.33/ 
0.39* 
0.1041/ 
0.0608* 
Insulin –0.01 0.9734     
HOMA-IR 0.01 0.9735     
Ρ (rho): Spearman’s correlation coefficient, *ignoring the outlier value 
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Fig. 2. Relationship between serum leptin and visceral depot (IAFxL2) in dogs.  
Solid line: lowess nonparametrics regression line; broken line: least-square regression line 
 
 
Discussion 
Abdominal fat distribution 
The variance in fat deposition is an important similarity between humans 
and dogs, nevertheless there is no publication about the types of obesity (vis-
ceral-subcutaneous, android-gynoid) or about the differences in the distribution 
of abdominal fat in dogs. Our data showed differences in the regionality of fat 
deposits. Canine patients had either visceral or subcutaneous type of deposits 
where the major part of abdominal fat stayed. Although Bergman et al. (2006) 
reported a tendency for visceral adiposity to increase rapidly as the body fat of 
dog increases, and also that subsequently the visceral fat accumulation tends to 
plateau and subcutaneous fat increases more rapidly with overall obesity, we 
have not found this regularity in our studies. The increase in the amount of vis-
ceral fat was not followed by the regular change of abdominal subcutaneous de-
pot. The distribution of abdominal fat tissue varies greatly regardless of the BCS 
category. However, we can talk about tendencies only since our samples did not 
cover all BCS categories and the number of cases differed substantially in the dif-
ferent categories. By comparing the results of individuals in BCS3 and BCS4 cate-
gories, the greater amount of subcutaneous and visceral fat at the L2 and L3 levels 
in subjects with higher BCSs could clearly be seen, but an assessment of the ratio 
of depots by BCS category was not feasible. Based on our results, CT can success-
fully be applied for the determination of abdominal fat distribution in dogs. 
IAFxL2 
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Abdominal fat distribution and leptin level 
Leptin concentrations were significantly higher in dogs with higher BCSs 
in our study. Although the standard deviation of the measured leptin levels at 
each BCS was high (this can be possibly avoided in future examinations by using 
more objective body condition estimating methods or the 9-point BCS scale), 
these data were roughly of the same magnitude as data reported in the literature 
(Ishioka et al., 2007). There was a significant positive correlation between serum 
leptin concentration and the area of subcutaneous and visceral fat tissues. The 
amount of visceral fat showed a higher correlation with leptin concentration than 
that of subcutaneous fat. Overall, leptin concentration is also significantly corre-
lated with abdominal fat distribution in the dog but, unlike in humans, leptin 
level could best be predicted from the visceral depot. Then again, leptin levels 
showed no correlation with the fat distribution. These findings are in contradic-
tion with those of human studies, which reported that the leptin secretion rate is 
higher in subcutaneous than in omental fat tissue, which can be traced back to 
increased cell size and leptin gene expression (Hube et al., 1996). The higher ex-
pression in the falciform ligament may partially explain why the amount of vis-
ceral adipose tissue is the main determinant of serum leptin levels in dogs (Ryan 
et al., 2010). The other factor that can explain the differences is the size of the 
adipocytes (Wåhlen et al., 2011). In a canine model it has been demonstrated that 
adipocytes from the visceral depot are larger than subcutaneous fat cells, and that 
fat feeding increases adipocyte size in both depots; however, while feeding a 
high fat diet, a modest increase was shown in cell size and number in the subcu-
taneous fat tissue. Besides the relevant adipocyte enlargement, no hyperplasia 
was observed in visceral depots (Kabir et al., 2011). 
Abdominal fat distribution and insulin sensitivity 
The amount of visceral fat has a strong association with disturbances in in-
sulin action (Cnop et al., 2002). Investigators demonstrated in a dog model that a 
minimal reduction in visceral fat mass may result in an improvement in insulin 
sensitivity (Lottati et al., 2009). Other authors have reported that the abdominal 
subcutaneous fat is the major determinant of insulin sensitivity (Goodpaster et 
al., 1997). Our findings showing a positive correlation between insulin concen-
tration and abdominal visceral to subcutaneous fat volume ratio are in line with 
the above results. A similar trend was observed in the relationship of fat ratio 
with HOMA-IR. These results are consistent with the conclusions of human 
studies that the intraabdominal to abdominal subcutaneous fat volume ratio was 
in close relationship with metabolic disorders (Fujioka et al., 1987). Despite this 
and unlike in many previous communications, insulin level and HOMA-IR value 
showed no correlation with visceral or subcutaneous adiposity. 
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Leptin, insulin and insulin sensitivity 
Leptin inhibits insulin secretion and has anti-insulin effects (Girard, 1997). 
It has been demonstrated in mouse models that disruption of leptin signalling re-
sults in the dysregulation of the insulin secretion and in whole-body insulin resis-
tance (Levi et al., 2011). Leptin might mediate compensatory increases in insulin 
secretion in obese dogs; however, in contrast to humans, supraphysiological con-
centrations of leptin do not inhibit insulin secretion in normal lean dogs (Verkest 
et al., 2011). According to our findings, the insulin level and HOMA-IR index 
tended to decline in dogs with higher BCS categories. Furthermore, there was a 
positive correlation between the visceral to subcutaneous fat ratio and insulin 
concentration. A similar trend was observed in the relationship between the fat 
ratio and HOMA-IR as well. In spite of this, there was no difference in insulin 
level or sensitivity between the BCS categories and the leptin concentration did 
not correlate with insulin level or HOMA-IR. Although insulin also plays an im-
portant role in chronic regulation of leptin secretion (Malmström et al., 1996), 
our results showed that fasting serum insulin and HOMA-IR were not predictors 
of leptin levels, neither these nor the amount of abdominal subcutaneous fat tis-
sue influenced the relationship between leptin levels and visceral fat volume. 
Since the standard deviation in insulin concentration and HOMA-IR values in-
creased with increasing visceral fat, it can be concluded that the increase in the 
amount of fat is not a direct cause of resistance but it predisposes to decreased 
insulin sensitivity. Regarding obese dogs, two groups should be distinguished. 
One type is obese dogs with metabolic disorders. The background of this form 
may also be endocrine abnormalities or existing disturbances of the compensa-
tion process, which causes the deterioration of insulin sensitivity or the lack of 
insulin production. The other type is obesity caused by positive energy balance, 
when the metabolic balance is maintained despite the saturation of fat depots, de-
terioration in sensitivity is mild, and only a rise in insulin levels can be detected, 
which is the result of compensatory mechanisms. 
In conclusion, the CT image evaluation method developed in this study 
may contribute to the clinical diagnosis and the study of canine obesity, espe-
cially to studies on the relationship between fat distribution and obesity-
associated diseases. According to our results, leptin concentration is correlated 
with abdominal fat distribution, and it could appropriately be predicted from the 
amount of visceral fat. Unlike in humans, the deposited visceral fat is the main 
determinant of leptin levels in dogs, while the abdominal subcutaneous fat has 
little effect. Leptin levels, however, show no correlation with the ratio of depots. 
In contrast to the recently published assumptions, the correspondence of visceral 
fat and leptin concentration is not significantly affected by serum insulin levels 
or the degree of insulin resistance. On this basis, serum leptin levels may be a 
useful marker in analyses of abdominal body fat distribution in dogs. It is impor-
tant to take into account the differences between humans and dogs. The insulin 
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level and HOMA-IR index tend to decline in dogs with higher BCS categories. 
There is a positive correlation between intraabdominal fat to abdominal subcuta-
neous fat ratio and insulin concentration, and a similar trend can be observed in 
the relationship of fat ratio with HOMA-IR. Further histopathological works to 
measure fat cell size as well as leptin-receptor immunohistochemistry and blood 
chemistry are in progress to facilitate a better understanding of the effects of fat 
depots and their regionality in dogs. 
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